Trial Profile
Investigation of Psycliomotor and Cognitive Residual Effects After Single Oral Doses of Zolpidem Tartrate Extended Release 12.5 mg and Eszopielone 3 mg Compared to Placebo in Healthy Young Volunteers, Using Plurazepam 30 mg As An External Comparator.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2009
Price :
$35
*
At a glance
- Drugs Eszopiclone (Primary) ; Zolpidem (Primary)
- Indications Generalised anxiety disorder; Insomnia
- Focus Pharmacodynamics
- Sponsors Sanofi
- 12 Sep 2006 New trial record.